Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLRMT | O00411 | 1/20 | 0.41 |
| ▸ | FGFR1 | P11362 | 3/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.35 |
| ▸ | P2RY10 | O00398 | 1/20 | 0.33 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.33 |
| ▸ | ADK | P55263 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25077109 | 1.00 | POLRMT (0.41) | POLRMTFGFR1CYP3A4CYP2D6P2RY10 | |
| SCHEMBL25766615 | 0.98 | POLRMT (0.42) | POLRMTFGFR1CYP3A4CYP2D6S1PR3 | |
| SCHEMBL25770236 | 0.98 | POLRMT (0.42) | POLRMTFGFR1CYP3A4CYP2D6S1PR3 | |
| SCHEMBL25766720 | 0.88 | POLRMT (0.39) | POLRMTFGFR1CYP3A4CYP2D6P2RY10 | |
| SCHEMBL25770214 | 0.88 | POLRMT (0.39) | POLRMTFGFR1CYP3A4CYP2D6P2RY10 | |
| SCHEMBL25077197 | 0.88 | POLRMT (0.43) | POLRMTFGFR1CYP3A4CYP2D6P2RY10 | |
| SCHEMBL25077291 | 0.86 | POLRMT (0.45) | POLRMTFGFR1CYP3A4CYP2D6S1PR3 | |
| SCHEMBL25077145 | 0.85 | POLRMT (0.41) | POLRMTFGFR1CYP3A4CYP2D6S1PR3 | |
| SCHEMBL25770198 | 0.85 | POLRMT (0.41) | POLRMTFGFR1CYP3A4CYP2D6S1PR3 | |
| SCHEMBL25768624 | 0.85 | POLRMT (0.41) | POLRMTFGFR1CYP3A4CYP2D6S1PR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230212199-A1 | PHOSPHOLIPID COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | GILEAD SCIENCES, INC. | 2023-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230212199-A1 | PHOSPHOLIPID COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | PHOSPHO1, SGMS1, SGMS2 | POLRMT 266/4885FGFR1 4854/4885CYP3A4 2080/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.